» Articles » PMID: 23801847

Colonic Mucormycosis Presented with Ischemic Colitis in a Liver Transplant Recipient

Overview
Specialty Gastroenterology
Date 2013 Jun 27
PMID 23801847
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Mucormycosis is an uncommon opportunistic fungal infection with high mortality in liver transplant recipients. Mucormycosis of the gastrointestinal tract can manifest with features similar to ischemic colitis. Typically signs and symptoms of non-gangrenous ischemic colitis resolve spontaneously within 24-48 h. On the other hand, the clinical course of the mucormycosis is commonly fulminant. We encountered a case of invasive fungal colitis presenting with abdominal pain and hematochezia in a liver transplant recipient. Endoscopic examination showed multiple shallow ulcerations and edema with mucosal friabilities on the sigmoid and distal descending colon, which was consistent with ischemic colitis. However, the histological examination obtained from endoscopic biopsies showed fungal hyphae with surrounding inflammatory cells and mucosal necrosis. The patient was successfully managed with antifungal agent without surgical treatment. Thus, early diagnosis and treatment is essential for improving the prognosis of invasive fungal infection after liver transplantation.

Citing Articles

Epidemiology, Clinical Manifestations, and Outcome of Mucormycosis in Solid Organ Transplant Recipients: A Systematic Review of Reported Cases.

Palomba E, Colaneri M, Azzara C, Fava M, Maccaro A, Renisi G Open Forum Infect Dis. 2024; 11(6):ofae043.

PMID: 38887489 PMC: 11181195. DOI: 10.1093/ofid/ofae043.


CT appearance of gastrointestinal tract mucormycosis.

Ghuman S, Sindhu P, Buxi T, Sheth S, Yadav A, Rawat K Abdom Radiol (NY). 2020; 46(5):1837-1845.

PMID: 33170347 DOI: 10.1007/s00261-020-02854-3.


Gastrointestinal mucormycosis initially manifest as hematochezia from arterio-enteric fistula.

Cloyd J, Brown J, Sinclair T, Jenks D, Desai J, Longacre T Dig Dis Sci. 2014; 59(12):2905-8.

PMID: 24906697 DOI: 10.1007/s10620-014-3239-7.

References
1.
Mezhir J, Mullane K, Zarling J, Satoskar R, Pai R, Roggin K . Successful nonoperative management of gastrointestinal mucormycosis: novel therapy for invasive disease. Surg Infect (Larchmt). 2009; 10(5):447-51. DOI: 10.1089/sur.2008.049. View

2.
Korkmaz M, Gur G, Yilmaz U, Karakayali H, Boyacioglu S, Haberal M . Colonoscopy is a useful diagnostic tool for transplant recipients with lower abdominal symptoms. Transplant Proc. 2004; 36(1):190-2. DOI: 10.1016/j.transproceed.2003.11.065. View

3.
Severo C, Guazzelli L, Severo L . Chapter 7: zygomycosis. J Bras Pneumol. 2010; 36(1):134-41. DOI: 10.1590/s1806-37132010000100018. View

4.
Singh N, Aguado J, Bonatti H, Forrest G, Gupta K, Safdar N . Zygomycosis in solid organ transplant recipients: a prospective, matched case-control study to assess risks for disease and outcome. J Infect Dis. 2009; 200(6):1002-11. DOI: 10.1086/605445. View

5.
Spellberg B, Edwards Jr J, Ibrahim A . Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev. 2005; 18(3):556-69. PMC: 1195964. DOI: 10.1128/CMR.18.3.556-569.2005. View